17th Sep 2024 16:17
Victrex PLC - Lancashire, England-based polymer solutions provider for automotive, aerospace, energy & industrial, electronics, and medical markets - Says US Food & Drug Administration has granted investigational device exemption approval for a staged study, in partnership with Maxx Orthopedics Inc, for Maxx's Freedom Total Knee System with Victrex's Invibio Peek-Optima Femoral Component. Study will be conducted in the US and compare the Peek-Optima component to a control group using traditional metal femoral components. Company notes that this study will build on the existing criminal trial in Belgium, Italy and India, "which has been progressing strongly since the first implant in 2021". It also expects a regulatory submission in India "imminently". Read More
